The registry of the german network for systemic scleroderma: Frequency of disease subsets and patterns of organ involvement

N. Hunzelmann, E. Genth, T. Krieg, W. Lehmacher, I. Melchers, M. Meurer, P. Moinzadeh, U. Müller-Ladner, C. Pfeiffer, G. Riemekasten, E. Schulze-Lohoff, C. Sunderkoetter, M. Weber, M. Worm, P. Klaus, A. Rubbert, K. Steinbrink, B. Grundt, R. Hein, K. Scharffetter-KochanekR. Hinrichs, K. Walker, R. M. Szeimies, S. Karrer, A. Müller, C. Seitz, E. Schmidt, P. Lehmann, I. Foeldvári, F. Reichenberger, W. L. Gross, A. Kuhn, M. Haust, K. Reich, M. Böhm, P. Saar, G. Fierlbeck, I. Kötter, H. M. Lorenz, N. Blank, K. Gräfenstein, A. Juche, E. Aberer, G. Bali, C. Fiehn, R. Stadler, V. Bartels

245 Citations (Scopus)

Abstract

Objective: Systemic sclerosis (SSc) is a rare, heterogeneous disease, which affects different organs and therefore requires interdisciplinary diagnostic and therapeutic management. To improve the detection and follow-up of patients presenting with different disease manifestations, an interdisciplinary registry was founded with contributions from different subspecialties involved in the care of patients with SSc. Methods: A questionnaire was developed to collect a core set of clinical data to determine the current disease status. Patients were grouped into five descriptive disease subsets, i.e. lcSSc, dcSSc, SSc sine scleroderma, overlap-syndrome and UCTD with scleroderma features. Results: Of the 1483 patients, 45.5% of patients had lcSSc and 32.7% dcSSc. Overlap syndrome was diagnosed in 10.9% of patients, while 8.8% had an undifferentiated form. SSc sine scleroderma was present in 1.5% of patients. Organ involvement was markedly different between subsets; pulmonary fibrosis for instance was significantly more frequent in dcSSc (56.1%) than in overlap syndrome (30.6%) or lcSSc (20.8%). Pulmonary hypertension was more common in dcSSc (18.5%) compared with lcSSc (14.9%), overlap syndrome (8.2%) and undifferentiated disease (4.1%). Musculoskeletal involvement was typical for overlap syndromes (67.6%). A family history of rheumatic disease was reported in 17.2% of patients and was associated with early disease onset (P < 0.005). Conclusion: In this nationwide register, a descriptive classification of patients with disease manifestations characteristic of SSc in five groups allows to include a broader spectrum of patients with features of SSc.

Original languageEnglish
JournalRheumatology
Volume47
Issue number8
Pages (from-to)1185-1192
Number of pages8
ISSN1462-0324
DOIs
Publication statusPublished - 08.2008

Funding

Funding: This study was supported by the German Federal Ministry of Education and Research (BMBF) (01GM0310). Funding to pay the Open Access publication charges for this article was provided by Koeln Fortune. To date, there exist no data on the occurrence of these additional disease subsets in a large population. In order to improve clinical care and to develop recommendations for the diagnosis and treatment of SSc, the German Network for Systemic Scleroderma (DNSS) was established in October 2003, funded by the German Federal Ministry of Education and Research (BMBF). A core activity of this network is a patient registry that comprises centres in all parts of Germany as well as one centre in Graz (Austria). A major goal of the network was to ensure acquisition of patients with different disease presentations and clinical variants of this heterogenous disease. This goal was not only facilitated by a country-wide network, but also by cooperation of different subspecialties being primarily involved in the care of patients with SSc in Germany, i.e. rheumatologists, dermatologists, pulmonologists and nephrologists.

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Fingerprint

Dive into the research topics of 'The registry of the german network for systemic scleroderma: Frequency of disease subsets and patterns of organ involvement'. Together they form a unique fingerprint.

Cite this